Karen Reckamp, MD | Authors

Articles

ALK+ mNSCLC: Advancements Made and What’s Next

April 19, 2021

An expert in the treatment of lung cancer gives insight for the sequencing of ALK inhibitors following disease progression, highlighting the instances of the development of brain involvement and rebiopsy.

Sequencing ALK Inhibitors

April 19, 2021

An expert in the treatment of lung cancer gives insight for the sequencing of ALK inhibitors following disease progression, highlighting the instances of the development of brain involvement and rebiopsy.